Xyosted 100 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRZ05
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,375
Award facts
- Contract value 100% obligated
- $1,375.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units valued at $1,375.49. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order represents a small-value transaction typical of the routine pharmaceutical procurement conducted through the DLA's Medical Supply Chain.
This award is issued as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and enables the company to supply a wide range of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Xyosted, a testosterone replacement therapy auto-injector, represents the type of specialized pharmaceutical commodity supported through this expansive contract framework serving defense and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FRZ05?
SPE2DB25FRZ05 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FRZ05 worth?
The government has obligated $1,375 on SPE2DB25FRZ05.
Is contract SPE2DB25FRZ05 an order under another contract?
Yes. SPE2DB25FRZ05 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRZ05 competed?
The extent of competition for SPE2DB25FRZ05 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award